GT Biopharma (GTBP) Price to Sales (2010 - 2015)

GT Biopharma (GTBP) has reported Price to Sales for 5 consecutive years, with 1946750.52 the latest figure, recorded in Q2 2015.

• On a quarterly basis, Price to Sales changed N/A year-over-year to 1946750.52 in Q2 2015; TTM through Mar 2016 was 5434.49, a 98.23% decrease from a year earlier, with the FY2015 full-year figure at 3409.4, down 99.61% from the prior year.
• Price to Sales was 1946750.52 for Q2 2015 at GT Biopharma, down from 13807389.05 in the prior quarter.
• Over five years, Price to Sales peaked at 53504406.44 in Q2 2011 and troughed at 101486.21 in Q4 2012.
• A 4-year average of 13993000.45 and a median of 5035121.16 in 2011 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales jumped 1024.76% in 2012 and slumped 99.04% in 2013, its largest moves.
• Over 4 years, Price to Sales stood at 5035121.16 in 2011, then tumbled by 97.98% to 101486.21 in 2012, then jumped by 189.18% to 293482.23 in 2013, then soared by 563.33% to 1946750.52 in 2015.
• The last three Price to Sales figures came in at 1946750.52 (Q2 2015), 13807389.05 (Q1 2015), and 293482.23 (Q1 2013), per Business Quant data.